Abbott LaboratoriesABTNYSE
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank64
5Y CAGR-9.6%
Year-over-Year Change
Year-over-year free cash flow growth rate
5Y CAGR
-9.6%/yr
Long-term compound
Percentile
P64
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 16.44% |
| 2024 | 25.54% |
| 2023 | -35.17% |
| 2022 | -9.76% |
| 2021 | 51.08% |
| 2020 | 27.26% |
| 2019 | -8.32% |
| 2018 | 10.62% |
| 2017 | 113.02% |
| 2016 | 12.18% |